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ABSTRACT
Motivation: Prediction of the interaction affinity between proteins and compounds is a major chal-
lenge in the drug discovery process. WideDTA is a deep-learning based prediction model that em-
ploys chemical and biological textual sequence information to predict binding affinity.
Results: WideDTA uses four text-based information sources, namely the protein sequence, ligand
SMILES, protein domains and motifs, and maximum common substructure words to predict binding
affinity. WideDTA outperformed one of the state of the art deep learning methods for drug-target
binding affinity prediction, DeepDTA on the KIBA dataset with a statistical significance. This indi-
cates that the word-based sequence representation adapted by WideDTA is a promising alternative
to the character-based sequence representation approach in deep learning models for binding affinity
prediction, such as the one used in DeepDTA. In addition, the results showed that, given the protein
sequence and ligand SMILES, the inclusion of protein domain and motif information as well as
ligand maximum common substructure words do not provide additional useful information for the
deep learning model. Interestingly, however, using only domain and motif information to represent
proteins achieved similar performance to using the full protein sequence, suggesting that important
binding relevant information is contained within the protein motifs and domains.
1 Introduction
Discovery of potential drugs for new targets is an expensive and time consuming process. Even though over 97M
compounds are deposited in PubChem database [1] (accession date: Jan 2019), the latest version (version 5.1.2) of
DrugBank [2] reports only around 12K drug entries. Considering the expansive search space, the development of
methodologies to predict the interactions between drugs and targets with high precision can be accelerated by the
recent advances in the artificial intelligence applications in chemical research.
Over the last decade, most studies employing traditional machine learning algorithms modelled the prediction of
the interaction between compounds and proteins as a binary classification problem (interacts or not) [3, 4, 5, 6, 7].
Recently, deep learning architectures have also become a popular choice in drug discovery studies. The success of
the first studies [8, 9] that employed deep neural networks (DNN) to model the interaction between proteins and
compounds over traditional machine-learning methods motivated later studies that adopted new architectures such as
convolutional neural networks (CNNs), recurrent neural networks (RNNs) [10, 11] and stacked-autoencoders [12].
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Binding affinity value, reported in several different metrics such as disassociation constant (Kd), inhibition constant
(Ki) or half maximal inhibitory constant (IC50), indicates the strength of the interaction between a ligand-protein
pair. Prediction of this valuable information about the interaction became a topic of interest later, with the studies
that adopted traditional machine learning algorithms such as Kronecker Regularized Least Squares (KronRLS) and
boosting machines (SimBoost) [13, 14]. Deep-learning based studies that aimed to predict bioactivity values of drug-
target complexes utilized DNN [15] and CNN based architectures using the detailed information that the 3D structures
provided [16, 17, 18, 19]. While the information that can be obtained from the 3D structure is very valuable in
highlighting the mechanistic information about the bimolecular interaction, these studies depend on the availability of
protein - ligand complex structures. The 3D structure of ligands in complex with a protein is known for only around
30000 compounds [20].
As an alternative to 3D-based deep learning approaches, our team proposed a CNN-based model that utilized text-
only features of the entities that participate in an interaction (i.e. protein sequences and the Simplified Molecular
Input Line Entry System (SMILES) notation of ligands) [21] and showed that the binding affinity can be predicted
successfully using only raw text data of protein - compound pairs and without depending on feature engineering. A
deep-learning based model that uses ExtendedConnectivity Fingerprints (ECFP) and graph-convolutionalnetworks for
the representation of compounds, and Protein Sequence Composition (PSC) for protein representation has shown that
ECFP is still a good rival to graph convolutional representation of molecules [22]. This model relies on descriptors that
can be obtained from the SMILES representation. Another recent protein-compound affinity prediction study showed
that compound embeddings obtained with SMILES-based long-short term memory (LSTM) model performed better
than embeddings obtained with graph-convolutional models [10]. These findings suggest that a text based approach,
which can take advantage of the advances in the natural language processing field, has high potential not only for its
simplicity and for the availability of more data, but also because of its representation capability and high performance.
In this study, we propose a methodology to predict protein-ligand binding affinity through text-only information of
both proteins and compounds. Without relying on 3D structure information of the complex or 2D representation of
the compound, we learn high dimensional features from sequences of the proteins and ligands. One of the interesting
outcomes of the DeepDTA model was the observation of the difficulty of modelling proteins using their sequences
[21]. When modelled by CNN-based modules separately, the CNN module was not as good at describing proteins as
it was with SMILES in the affinity prediction task. We suggested that, since the full length sequence was used, the
biologically important short subsequences that would be more powerful at representing the protein were lost due the
low signal to noise ratio [21]. In order to overcome this problem, we propose to integrate different pieces of text-based
information in the WideDTA model to provide a better representation of the interaction. We still utilize the protein
sequence and ligand SMILES string by representing them as a set of words. A word of a protein sequence corresponds
to a three-residue subsequence, whereas a word of a ligand is equal to an 8-character subsequence extracted with a
sliding window approach [23]. In addition, we use two textual information sources that can provide valuable clues
about the specificity of the interaction.
The first piece of informationwe add to ourwords is protein motif and/or domain information. We utilize the PROSITE
database [24] to extract motifs and profiles that are associated with a biologically significant function and domain.
Then, we benefit from a recent study that showed that maximum common substructures (MCS) of ligands constitute
the actual words in the chemical space [25]. Approximately 100K MCS were used to extract a new set of words from
the ligands. Together, these four text-based information sources constitute the WideDTA model.
The results indicate that WideDTA (CI, 0.875) outperforms DeepDTA (CI, 0.863) on the KIBA dataset with statistical
significance (p-value of 0.001) in terms of the CI metric. WideDTA, which is built on only the words extracted from
protein sequence and ligand SMILES (0.874) also performs better than DeepDTA, which is a character based model,
with a statistical significance (p-value of 0.0005) in terms of CI score. We suggest that word-based approach can be a
promising alternative to character-based models in this task.
2 Methods
2.1 Dataset
We used Davis [26], a selectivity assay data for Kinase family proteins, and KIBA [27] as benchmark datasets to
evaluate the proposed model. The Davis dataset includes the disassociation constant (pKd) values for about 30K
interactions, 69% of which have affinity values of 10000 nM (pKd=5) indicating weak or no interaction. KIBA,
on the other hand, has about three-times more interactions with KIBA scores. KIBA values are computed from the
combination of heterogenous information sources such as IC50,Ki andKd. We used the filtered version of the KIBA
dataset, in which each protein and ligand has at least ten interactions [14]. Table 1 summarizes the statistics of the
datasets.
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Table 1: Data set
Proteins Compounds Interactions
Davis (pKd) 442 68 30056
KIBA 229 2111 118254
2.2 Representation Modules
In this study, we used four different text-based information sources to model proteins and ligands. Our previous work
showed that the use of protein sequence and ligand SMILES is an effective approach to model the interactions between
these entities [21]. In this study, we explore the effect of adding additional pieces of specific information, namely
domain/motif information for the proteins and maximum common substructure information for the compounds, which
might contribute to a better modelling of the interactions.
2.2.1 Protein Sequence (PS)
The protein sequence is composed of 20 different types of amino acids (aa). In this study, we first collected the
sequences of the respective proteins from UniProt [28] for each dataset and then, extracted 3-residue words from the
sequences similarly to previous studies [29].
For instance, an example protein Kinase SGK1 (UniProt, O00141) with the sequence of “MTVKTEAAKGTLTYS-
RMRGMVA......YAPPTDSFL" is represented with the following set of words { ‘MTV’, ‘KTE’, ..., ‘TDS’, ‘TVK’,
‘TEA’, ..., ‘DSF’, ‘VKT’, ‘EAA’, ..., ‘SFL’}. We will refer to these words that are extracted from the whole protein
sequence as PS.
2.2.2 Protein Domains and Motifs (PDM)
PROSITE is database that serves as a resource for motif and profile descriptors of the proteins [24]. Multiple sequence
alignment of protein sequences reveals that specific regions within the protein sequence are more conserved than
others, and these regions are usually important for folding, binding, catalytic activity or thermodynamics. These
subsequences are called either motifs or profiles. A motif is a short sequence of amino-acids (usually 10-30 aa),
while profiles provide a quantitative measure of sequences based on the amino-acids they contain. Profiles are better
at detection of domains and families. For instance, Kinase SGK1 (UniProt, O00141) has the ATP-binding motif
‘IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK’, while the Protein Kinase Domain profile is about seven times
longer than the motif.
We used the PROSITE database to extract motifs and profiles for each respective protein in our datasets. We then
extracted 3-residue subsequences from each motif and domain similarly to the approach adopted in PS. We will refer
to this information module as PDM.
2.2.3 Ligand SMILES (LS)
A chemical compound can be represented with a SMILES string, which is a syntax that is used to represent atoms,
bonds etc. of a molecule with 64 special characters. Canonicalization of a SMILES string is a critical generalization
problem because different databases adopt different features in their canonicalization algorithms. Here, we collected
the respective SMILES from the PubChem database for all compounds.
Similarly to protein sequences, we extracted consecutive overlapping k-mers from the SMILES strings. We refer to
these k-mers as “chemical words". For instance the SMILES string “C(C1CCCCC1)N2CCCC2" is divided into the
following 8-character chemical words: “C(C1CCCC", “(C1CCCCC", “C1CCCCC1", “1CCCCC1), “CCCCC1)N",
“CCCC1)N2", ... , “)N2CCCC2". We experimented with k ranging between the values of 7-12 and there was no
statistically significant difference in the prediction performance, therefore we chose 8 to be the character length similar
to our previouswork [30]. A recent study by [25] also showed that most of the maximum common substructures (MCS)
in drugs had between 8 and 12 characters.
We utilized a recent methodology that modifies the syntax of SMILES representation, namely DeepSMILES [31].
DeepSMILES modifies the use of parentheses and ring closure digits in the regular SMILES and aims to enhance the
performance of the machine learning algorithms that employ SMILES notation as input in various different tasks. We
first extracted the canonical SMILES of the compounds from PubChem [32], and then converted each SMILES to
DeepSMILES (version 1.0.1). For instance the SMILES string “C(C1CCCCC1)N2CCCC2" is represented as “CCC-
CCCC6))))))NCCCC5" and the chemical words are: “CCCCCCC6", “CCCCCC6)", “CCCCC6))", ... , “))NCCCC5"
with DeepSMILES.
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2.2.4 Ligand Maximum Common Substructures (LMCS)
[25] recently published an interesting study on the properties of “words" in chemical space. Rather than using the
widely accepted functional groups as chemical words, they speculated that the patterns that the chemists use to dis-
tinguish sets of molecules, such as maximum common substructures (MCS), are the “chemical words" [25]. In order
to construct the vocabulary of chemical words, the authors performed a pairwise comparison of approximately 2K
molecules. In this study, we used the top 100K most frequent MCS, kindly provided to us by the authors to extract
chemical words from the SMILES strings of the ligands in our datasets.
For instance, for the example SMILES string “C(C1CCCCC1)N2CCCC2", we extract the followingMCS { ‘CCCCC’,
‘CCCC’, ‘CCC’, ‘CC’, ‘C1CCCCC1’}. However, since we represent the SMILES in DeepSMILES syntax, we actu-
ally work with “CCCCCCC6))))))NCCCC5". Thus, to be able to extract MCS from DeepSMILES syntax, we also
converted each MCS into DeepSMILES syntax. Eventually, we extracted the following set of MCS { ‘CCCCCC’,
‘CCCCCCC’, ‘CCCCC’, ‘CCCC’, ‘CCC’, ‘CC’, ‘CCCCCCC6’, ‘CCCCCC6’ }. The number of MCS captured with
DeepSMILES was thus higher, due to the absence of parentheses and ring numbers.
We will refer to the inputs obtained from MCS as LMCS throughout the article.
2.3 Representation of text-based modules
In this study, we proposed a word-based model instead of a character based model because of two reasons: (i) motifs
and domains that were extracted from a protein sequencewere not sequential and they can contain overlapping residues,
(ii) MCS words can contain overlapping characters.
Figures 1 and 2 illustrate the distribution of the number of words that are extracted from each information source versus
how many proteins/ligands contain the corresponding number of words for the Davis and KIBA datasets, respectively.
Figure 1: Davis dataset - Distribution of number of words.
For instance in Figure 1A, we observe that more than 100 proteins have around 500 three-residued words, which also
gives us an opinion about the length of an average protein (consisting of words). We should note that these words are
not unique, but might re-occur in the same protein/ligand. We can also articulate that for both of the datasets protein
sequences produce the most number of words, whereas MCS produces the least.
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Figure 2: KIBA dataset - Distribution of number of words.
As for modeling these words, each information source was fed into a respective module that consists of two 1D-
convolutional layers with a max pooling layer on top, which in turn output abstract features from these raw text inputs.
We used integer/label encoding, which uses integers for the categories to represent the inputs. We assigned a unique
integer to the words that we extracted from the sequences. For instance, for the LS module our sample SMILES
“C(C1CCCCC1)N2CCCC2" was represented as follows:[
C(C1CCCC (C1CCCCC C1CCCCC1 ... )N2CCCC2
1 3 8 ... 71
]
in which each integer is associated with a unique 8-character word.
2.4 Prediction Model: WideDTA
In this study, we propose a CNN-based model, which we call WideDTA, that combines at most four pieces of different
textual information. We used a similar architecture to the CNN-based DeepDTA method, which was previously pro-
posed by our team [21] (https://github.com/hkmztrk/DeepDTA). We should note that DeepDTA is a character based
model, whereas WideDTA depends on words as input.
For each text-based information module, we used two 1D-convolutional layers with a max pooling layer on top and
Rectified Linear Unit (RELU) as the activation function. We used 32 filters in the first CNN layer, and 64 in the
second level CNN in order to capture more specific patterns. Features extracted from these blocks were concatenated
and fed into three fully connected layers with the number of nodes (1024, 1024, 512), which had two drop-out layers
in between (value of 0.3) to prevent over-fitting. The proposed model that combines a total of four CNN blocks is
illustrated in Figure 3.
We used Keras’ Embedding layer to represent words with 128-dimensional dense vectors to fed integer encoded inputs.
The input for the Davis data set consisted of (85,128), (1000, 128), (500, 128), and (30, 128) dimensional matrices for
the compounds and proteins, domains and motifs, and MCS, respectively. We represented the KIBA data set with a
(100,128), (1000, 128), (650, 128), (35, 128) dimensional matrices for the compounds, proteins, domains and motifs,
and compound MCS, respectively. We chose the maximum lengths based on the distribution of the words for each
dataset, illustrated in Figures 1 and 2.
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Figure 3: Combination of CNN modules constructs the WideDTA architecture.
The model was developed on Keras environment [33] with Tensorflow [34]. We evaluated the performance of the
presented models on the benchmark datasets Davis [26] and KIBA [27] and used the same training and test folds for
all experiments. In these folds, both datasets were randomly divided into six equal parts and one part was separated
as the independent test set. The remaining parts of the data sets were used to determine the hyper-parameters with
cross-validation.
2.5 Evaluation
The performance of the proposed model was measured by calculating the Concordance Index (CI) and Mean Squared
Error (MSE) metrics. CI evaluates the ranking performance of the models that output continuous values [35]:
CI =
1
Z
∑
δx>δy
h(bx − by) (1)
where bx is the prediction value for the larger affinity δx, by is the prediction value for the smaller affinity δy , Z is a
normalization constant, h(m) is the step function [13]:
h(m) =


1, ifm > 0
0.5, ifm = 0
0, ifm < 0
MSE measures the difference between the predicted values (p) and the vector of actual values (y). For the Davis
dataset the compared values are pKd while for the KIBA dataset the values areKIBA scores. n indicates the number
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of samples.
MSE =
1
n
n∑
k=1
(pk − yk)
2 (2)
We also utilized Pearson correlation coefficient, which is explained in Equation 3, to measure the difference between
the true values and the predicted values of binding affinity [36]. cov indicates the co-variance between predicted values
p and original values y, where σ represents the standard deviation.
Pearson =
cov(p, y)
σpσy
(3)
Statistical significance tests were performed by paired t-test with 95% confidence interval.
2.6 Baseline
We compared the method presented here with two state of the art models that employ traditional machine learning
methods. The first study uses Kronecker-Regularized Least Squares (KronRLS) algorithm to predict binding affinity
in which both proteins and compounds are represented with their pairwise similarity score matrices [13]. In order
to compute similarity between proteins and between compounds, Smith-Waterman (S-W) algorithm and PubChem
structure clustering tool (http://pubchem.ncbi.nlm.nih.gov) were utilized, respectively. In the second study, a gradient
boosting machine based method, namely SimBoost, is employed for the prediction of the binding affinity [14]. The
presented approach depends on feature engineering of compounds and proteins utilizing information such as similarity
and network-inferred statistics. We also compared our results with DeepDTA [21], which is a deep-learning based
method that outperformed the aforementioned methods.
3 Results
In this study, we introduce a model to predict the binding affinity of the interactions between proteins and ligands using
a deep learning based model, WideDTA. The proposed model incorporates up to four text-based information sources:
complete sequence, motif and domain sequences for proteins, SMILES-based words and maximum common substruc-
tures (MCS) for ligands. We should note that DeepSMILES syntax was used throughout the work and SMILES here
refers to DeepSMILES.
Tables 2 and 3 report the average MSE, CI and Pearson scores over the independent test set utilizing different set of
features for the prediction of binding affinity for the Davis and KIBA datasets, respectively. We assessed the effect
of using different features, starting with different pairs of information sources such as protein sequence and ligand
SMILES or protein sequence and MCS, and then adding each feature one by one until the four modules are combined.
In the Davis dataset, we obtain CI value of 0.875 and MSE of 0.295 when we use full length protein sequence (PS)
and ligand SMILES (LS). Comparison of the pairwise models favors two modules, PDM (protein domain and motif)
and LMCS (ligand maximum common substructure) with higher CI value (0.883) and lower MSE value (0.276). Even
though the improvement over PS (protein sequence) and LS (ligand SMILES) pair is not statistically significant, we
choose to append a third information module, PS, to the PDM+LMCS pair because this combination has the best
performance. This triplet improves the prediction performance in terms of CI and MSE values. Finally, combination
of the four modules produces the best performance in terms of MSE and Pearson correlation values.
Table 2: CI, MSE, and Pearson Correlation Coefficient values for the Davis dataset on the independent test set using
the WideDTA model. Standard deviations are given in parenthesis.
Protein Compound Evaluation
Method PS PDM LS LMCS CI MSE Pearson
WideDTA 1 0 1 0 0.875 (0.008) 0.295 (0.029) 0.807 (0.009)
WideDTA 0 1 1 0 0.876 (0.009) 0.311 (0.028) 0.806 (0.008)
WideDTA 1 0 0 1 0.879 (0.003) 0.284 (0.022) 0.807 (0.006)
WideDTA 0 1 0 1 0.883 (0.003) 0.276 (0.009) 0.813 (0.003)
WideDTA 1 1 0 1 0.885 (0.003) 0.267 (0.002) 0.814 (0.003)
WideDTA 1 1 1 1 0.886 (0.003) 0.262 (0.009) 0.820 (0.006)
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As for the KIBA dataset, we observed that PS and LS pair provided the best CI (0.874) and MSE (0.179) values,
therefore this pair was selected as a starting point to add new modules. The performance of the model represented
with this pair was higher than the model with PS and LMCS with a statistical significance in terms of CI, MSE and
Pearson metrics (p-value of 0.0001 for all). We suggest that LS, which uses chemical words extracted from SMILES,
may be a better representation module than LMCS, the maximum common substructure words. The inclusion of PDM
does not significantly affect the performance, nor does the inclusion of the PDM and LMCS together, even though
there are slight improvements with the three-module and four-module systems.
Table 3: CI, MSE, and Pearson Correlation Coefficient values for the KIBA dataset on the independent test set using
the WideDTA model. Standard deviations are given in the parenthesis.
Protein Compound Evaluation
Method PS PDM LS LMCS CI MSE Pearson
WideDTA 1 0 1 0 0.874 (0.0002) 0.179 (0.005) 0.855 (0.002)
WideDTA 0 1 1 0 0.873 (0.001) 0.182 (0.004) 0.851 (0.002)
WideDTA 1 0 0 1 0.850 (0.002) 0.238 (0.007) 0.803 (0.006)
WideDTA 0 1 0 1 0.849 (0.002) 0.237 (0.006) 0.805 (0.003)
WideDTA 1 1 1 0 0.873 (0.001) 0.180 (0.002) 0.854 (0.001)
WideDTA 1 1 1 1 0.875 (0.001) 0.179 (0.008) 0.856 (0.003)
Inclusion of domain and motif information for proteins did not lead to a significant improvement in prediction ability
in either dataset. This may be an expected result for these datasets, both of which belong to the kinase family, whose
members have similar motifs and domains. In both datasets, the four major domains and motifs that dominated
the information were: kinase domain (PROSITE ID: PS50011), kinases ATP-binding region signature (PROSITE
ID: PS00107), Serine/Threonine protein kinases active-site signature (PROSITE ID: PS00108) and Tyrosine protein
kinases specific active-site signature (PROSITE ID: PS00109).
We should however highlight that the models that use domains and motifs alone provided similar performances to
the models that use full protein sequence. Thus, we can suggest the use of domain and motif information, which in
fact constitute a small portion of a sequence, might be a more informative alternative to full sequence. Even though
sharing the aforementionedmajor domains and motifs, majority of the domains andmotifs extracted from both datasets
(Davis, 70% and KIBA, 75%) appear in five or less ligands which is an indication of motifs and domains capturing the
distinctiveness.
We observed that the use of maximum common substructure words provided a slight improvement over SMILES based
8-character words (LS) for the Davis dataset, but led to a significantly worse performance for the KIBA dataset. We
might still argue that MCS words distinguish between the characteristics of different molecules considering that the
percentage of the unique MCS words that appear in five or less ligands comprise the majority of all MCS words that
are extracted from both datasets (Davis, 71% and KIBA, 69% ). However, LS has more of an advantage over MCS
words by means of the sliding window approach that might produce words with slight character changes.
We finally compared the performance of the best WideDTA combination with traditional machine learning based
methodsKronRLS [13] and SimBoost [37] and deep-learning based state of the art DeepDTA [21], which is a character-
based model that utilizes the complete sequence of proteins and the SMILES of the compounds. Tables 4 and 5 report
the performance comparison in terms of CI and MSE metrics.
Table 4: CI and MSE values for Davis dataset on the independent test set for WideDTA and other state-of-art models.
Standard deviations are given in the parenthesis.
Method Proteins Compounds CI MSE
KronRLS S-W PubChem Sim 0.871 (0.0008) 0.379
SimBoost S-W PubChem Sim 0.872 (0.002) 0.282
DeepDTA PS (char) LS (char) 0.878 (0.004) 0.261
WideDTA (best) PS + PDM LS + LMCS 0.886 (0.003) 0.262
On both datasets, the best combinations ofWideDTA outperforms the current state of the art machine learningmethods,
KronRLS and SimBoost, as well as the deep learning based approach DeepDTA. On the KIBA dataset, the best model
produces a CI score (0.875) better than DeepDTA (0.863) with statistical significance (p-value of 0.001). WideDTA
with only LS and PS as information (CI score of 0.874) still outperforms DeepDTA (CI score 0.863), which is a
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character based model with a statistical significance (p-value of 0.0005). We observe that use of words instead of
characters can be more informative for the task of protein-ligand interaction prediction.
Table 5: CI and MSE values for KIBA dataset on the independent test set for WideDTA and other state of the art
models. Standard deviations are given in the parenthesis.
Method Proteins Compounds CI MSE
KronRLS S-W Pubchem Sim 0.782 (0.0009) 0.411
SimBoost S-W Pubchem Sim 0.836 (0.001) 0.222
DeepDTA PS (char) LS (char) 0.863 (0.002) 0.194
WideDTA (best) PS + PDM LS + LMCS 0.875 (0.001) 0.179
3.1 Biological Interpretation
We investigated a sample protein, human cell cycle checkpoint kinase Chk1 (UniProt, O14757), from KIBA dataset
and its corresponding predictions by comparing the performance of the model where all modules are included with
the model where only PDM and LMCS modules are used in order to elucidate why MCS words fail to describe the
molecules in the KIBA dataset.
We selected a case where PS + PDM + LS + LMCS achieved better performance (predicted, 10.60, 10.47) at predicting
the actual weak binding affinities (real value, 10.20, 10.40) for two sample ligands compared to the PDM + LMCS
model (predicted, 11.34, 11.18).
We inspected these two ligands, Pubchem IDs 404051 (N-(3-Chlorophenyl)-4-methoxybenzamide) and 324081 (4-
Anilinoquinazoline) in terms of chemical words and MCS words. Even though MCS words succeeded in capturing
the following pattern in two of the ligands, “C=CC=CC=C", LS chemical words were also able to capture the similar
pattern with “C=CC=CC=C6))", but with several words such as ‘C=CC=CC=’, ‘=CC=CC=C’ and ‘CC=CC=C6’.
However LS also uncovered words such as ‘NC=NC=NC’ and ‘NC=NC=CC’ that point out a similar substructure.
Since these chemical words are created with a sliding window approach, every character change (e.g. an atom at the
end of the word) leads to a new word. Therefore, we suggest that comprising words that are one character away might
help filters of the CNN to capture the similarity between the words such as ‘NC=NC=NC’ and ‘NC=NC=CC’.
4 Conclusion
With this study, we proposed a deep-learning based approach to predict drug-target binding affinity, which we refer
to as WideDTA. WideDTA combines four different textual pieces of information related to proteins and ligands. For
proteins we used the complete amino acid sequences as well as the domains and motifs extracted from the PROSITE
database. The protein sequence, domains and motifs were all represented as a set of 3-residue words, whereas for lig-
ands, 8-character chemical words andmaximum common substructure (MCS) words were extracted from the complete
SMILES strings.
The results showed that even in the absence of information provided by domains and motifs and MCS words, protein
sequence and ligand SMILES text alone provided comparable and significantly better performances than the state of
the art deep learning approach, namely DeepDTA, on the Davis and KIBA datasets. DeepDTA is a character based
approach [21], whereas WideDTA uses word representations. Our results suggest that the word based approach has
higher performance than a character based approach.
Despite our expectation that adding the protein domain and motif information extracted from the PROSITE database
would improve the protein representation and hence the prediction performance, we could not observe a statistically
significant improvement in the predictive power with the addition of this information. We realize that one limitation of
the current study is its focus on using two kinase benchmark datasets. Due to the similarity in the kinase structure and
motifs, including domain and motif information to the full protein sequence information does not provide additional
information that would distinguish the different proteins in the dataset. However, this information can be informative
in datasets that are more diverse.
We should however emphasize an interesting outcome of this work. The use of protein domains and motifs only,
which correspond to a smaller percentage of the full sequence, performed as well as the use of the complete protein
sequence. This is also supported by the dataset statistics that indicated that the majority of the unique domains and
motifs extracted from the proteins appear in five or less ligands, which in turn points out the captured individuality of
the proteins.
9
A PREPRINT - FEBRUARY 13, 2019
Acknowledgements
TUBITAK-BIDEB 2211-E Scholarship Program (to H.O.) and BAGEP Award of the Science Academy (to A.O.) are
gratefully acknowledged. We thank Maciej Eder and Nano Grzybowski for sharing the MCS vocabulary.
Funding
This work was supported by Bogazici University Research Fund (BAP) Grant Number 12304.
References
[1] Evan E Bolton, Yanli Wang, Paul A Thiessen, and Stephen H Bryant. Pubchem: integrated platform of small
molecules and biological activities. Annual reports in computational chemistry, 4:217–241, 2008.
[2] David S Wishart, Craig Knox, An Chi Guo, Savita Shrivastava, Murtaza Hassanali, Paul Stothard, Zhan Chang,
and Jennifer Woolsey. Drugbank: a comprehensive resource for in silico drug discovery and exploration. Nucleic
acids research, 34(suppl 1):D668–D672, 2006.
[3] Yoshihiro Yamanishi, Masaaki Kotera, Minoru Kanehisa, and Susumu Goto. Drug-target interaction prediction
from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics, 26(12):i246–
i254, 2010.
[4] Yong Liu, Min Wu, Chunyan Miao, Peilin Zhao, and Xiao-Li Li. Neighborhood regularized logistic matrix
factorization for drug-target interaction prediction. PLoS computational biology, 12(2):e1004760, 2016.
[5] André CA Nascimento, Ricardo BC Prudêncio, and Ivan G Costa. A multiple kernel learning algorithm for
drug-target interaction prediction. BMC bioinformatics, 17(1):1, 2016.
[6] Jongsoo Keum and Hojung Nam. Self-blm: Prediction of drug-target interactions via self-training svm. PloS
one, 12(2):e0171839, 2017.
[7] Peyton Greenside, Maureen Hillenmeyer, and Anshul Kundaje. Prediction of protein-ligand interactions from
paired protein sequence motifs and ligand substructures. In Pacific Symposium on Biocomputing, volume 23.
World Scientific, 2017.
[8] Thomas Unterthiner, Andreas Mayr, Günter Klambauer, Marvin Steijaert, Jörg K Wegner, Hugo Ceulemans, and
Sepp Hochreiter. Deep learning as an opportunity in virtual screening. In Proceedings of the deep learning
workshop at NIPS, volume 27, pages 1–9, 2014.
[9] Kai Tian, Mingyu Shao, Shuigeng Zhou, and Jihong Guan. Boosting compound-protein interaction prediction
by deep learning. In Bioinformatics and Biomedicine (BIBM), 2015 IEEE International Conference on, pages
29–34. IEEE, 2015.
[10] Andreas Mayr, Günter Klambauer, Thomas Unterthiner, Marvin Steijaert, Jörg K Wegner, Hugo Ceulemans,
Djork-Arné Clevert, and Sepp Hochreiter. Large-scale comparison of machine learning methods for drug target
prediction on chembl. Chemical Science, 2018.
[11] Kyle Yingkai Gao, Achille Fokoue, Heng Luo, Arun Iyengar, Sanjoy Dey, and Ping Zhang. Interpretable drug
target prediction using deep neural representation. In IJCAI, pages 3371–3377, 2018.
[12] Lei Wang, Zhu-Hong You, Xing Chen, Shi-Xiong Xia, Feng Liu, Xin Yan, Yong Zhou, and Ke-Jian Song. A
computational-based method for predicting drug–target interactions by using stacked autoencoder deep neural
network. Journal of Computational Biology, 2017.
[13] Tapio Pahikkala, Antti Airola, Sami Pietilä, Sushil Shakyawar, Agnieszka Szwajda, Jing Tang, and Tero Ait-
tokallio. Toward more realistic drug–target interaction predictions. Briefings in bioinformatics, page bbu010,
2014.
[14] Tong He, Marten Heidemeyer, Fuqiang Ban, Artem Cherkasov, and Martin Ester. Simboost: a read-across
approach for predicting drug–target binding affinities using gradient boosting machines. Journal of cheminfor-
matics, 9(1):24, 2017.
[15] Mahmudulla Hassan, Daniel Castaneda Mogollon, Olac Fuentes, et al. Dlscore: A deep learning model for
predicting protein-ligand binding affinities. 2018.
[16] Izhar Wallach, Michael Dzamba, and Abraham Heifets. Atomnet: a deep convolutional neural network for
bioactivity prediction in structure-based drug discovery. arXiv preprint arXiv:1510.02855, 2015.
10
A PREPRINT - FEBRUARY 13, 2019
[17] Joseph Gomes, Bharath Ramsundar, Evan N Feinberg, and Vijay S Pande. Atomic convolutional networks for
predicting protein-ligand binding affinity. arXiv preprint arXiv:1703.10603, 2017.
[18] Marta M Stepniewska-Dziubinska, Piotr Zielenkiewicz, and Pawel Siedlecki. Development and evaluation of a
deep learning model for protein-ligand binding affinity prediction. Bioinformatics, 1:9, 2018.
[19] José Jiménez Luna, Miha Skalic, Gerard Martinez-Rosell, and Gianni De Fabritiis. K deep: Protein-ligand
absolute binding affinity prediction via 3d-convolutional neural networks. Journal of chemical information and
modeling, 2018.
[20] Helen M Berman, John Westbrook, Zukang Feng, Gary Gilliland, Talapady N Bhat, Helge Weissig, Ilya N
Shindyalov, and Philip E Bourne. The protein data bank. Nucleic acids research, 28(1):235–242, 2000.
[21] Hakime Öztürk, Arzucan Özgür, and Elif Ozkirimli. Deepdta: deep drug–target binding affinity prediction.
Bioinformatics, 34(17):i821–i829, 2018.
[22] Qingyuan Feng, Evgenia Dueva, Artem Cherkasov, and Martin Ester. Padme: A deep learning-based framework
for drug-target interaction prediction. arXiv preprint arXiv:1807.09741, 2018.
[23] David Vidal, Michael Thormann, andMiquel Pons. Lingo, an efficient holographic text based method to calculate
biophysical properties and intermolecular similarities. Journal of chemical information and modeling, 45(2):386–
393, 2005.
[24] Christian JA Sigrist, Lorenzo Cerutti, EdouardDe Castro, Petra S Langendijk-Genevaux,Virginie Bulliard, Amos
Bairoch, and Nicolas Hulo. Prosite, a protein domain database for functional characterization and annotation.
Nucleic acids research, 38(suppl_1):D161–D166, 2009.
[25] Michał Woz´niak, Agnieszka Wołos, Urszula Modrzyk, Rafał L Górski, Jan Winkowski, Michał Bajczyk, Sara
Szymkuc´, Bartosz AGrzybowski, andMaciej Eder. Linguistic measures of chemical diversity and the “keywords”
of molecular collections. Scientific reports, 8, 2018.
[26] Mindy I Davis, Jeremy P Hunt, Sanna Herrgard, Pietro Ciceri, Lisa M Wodicka, Gabriel Pallares, Michael
Hocker, Daniel K Treiber, and Patrick P Zarrinkar. Comprehensive analysis of kinase inhibitor selectivity. Nature
biotechnology, 29(11):1046–1051, 2011.
[27] Jing Tang, Agnieszka Szwajda, Sushil Shakyawar, Tao Xu, Petteri Hintsanen, Krister Wennerberg, and Tero
Aittokallio. Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative
analysis. Journal of Chemical Information and Modeling, 54(3):735–743, 2014.
[28] Rolf Apweiler, Amos Bairoch, Cathy H Wu, Winona C Barker, Brigitte Boeckmann, Serenella Ferro, Elisabeth
Gasteiger, Hongzhan Huang, Rodrigo Lopez, Michele Magrane, et al. Uniprot: the universal protein knowledge-
base. Nucleic acids research, 32(suppl_1):D115–D119, 2004.
[29] Ehsaneddin Asgari and Mohammad RK Mofrad. Continuous distributed representation of biological sequences
for deep proteomics and genomics. PloS one, 10(11):e0141287, 2015.
[30] Hakime Öztürk, Elif Ozkirimli, and Arzucan Özgür. A novel methodology on distributed representations of
proteins using their interacting ligands. Bioinformatics, 34(13):i295–i303, 2018.
[31] Noel O’Boyle and Andrew Dalke. Deepsmiles: An adaptation of smiles for use in machine-learning of chemical
structures. ChemRxiv preprint, 2018.
[32] Yanli Wang, Stephen H Bryant, Tiejun Cheng, Jiyao Wang, Asta Gindulyte, Benjamin A Shoemaker, Paul A
Thiessen, Siqian He, and Jian Zhang. Pubchem bioassay: 2017 update. Nucleic acids research, 45(D1):D955–
D963, 2016.
[33] François Chollet et al. Keras, 2015.
[34] Martín Abadi, Ashish Agarwal, Paul Barham, Eugene Brevdo, Zhifeng Chen, Craig Citro, Greg S Corrado,
Andy Davis, Jeffrey Dean, Matthieu Devin, et al. Tensorflow: Large-scale machine learning on heterogeneous
distributed systems. arXiv preprint arXiv:1603.04467, 2016.
[35] Mithat Gönen and Glenn Heller. Concordance probability and discriminatory power in proportional hazards
regression. Biometrika, 92(4):965–970, 2005.
[36] Solomon Kullback and Richard A Leibler. On information and sufficiency. The annals of mathematical statistics,
22(1):79–86, 1951.
[37] Zhisong He, Jian Zhang, Xiao-He Shi, Le-Le Hu, Xiangyin Kong, Yu-DongCai, and Kuo-Chen Chou. Predicting
drug-target interaction networks based on functional groups and biological features. PloS one, 5(3):e9603, 2010.
11
